View O India Energy Outlook 2021 Report O Net Zero by 2050
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Asia COVID-19 & Vaccine Tracker
9 July 2021 Free to View Asia COVID-19 & Vaccine Tracker Economics - Asia Tougher restrictions As COVID-19 cases continue to surge across Asia, more Yun Liu authorities have re-imposed restrictions or even lockdowns Economist The Hongkong and Shanghai Banking Corporation Limited But this has increased the urgency to ramp up vaccine Frederic Neumann procurement and roll-out in the region Co-Head of Asian Economics Research The Hongkong and Shanghai Banking Corporation Limited Some economies have started pilot programmes to revive tourism, but a full re-opening may take a long time Maitreyi Das Associate Bangalore Déjà vu No end in sight just yet. The Delta variant is causing daily new COVID-19 cases to surge to new record highs across Asia, prompting more governments to re-impose tougher restrictions. This is particularly evident in ASEAN, where cases in Indonesia and Vietnam have been rising sharply. The former has extended its tightening measures throughout the country until 20 July, while the latter will impose a strict lockdown in Ho Chi Minh City (HCMC) from 9 July for 15 days. Meanwhile, just two weeks before the Tokyo Olympics, Japan is set to declare its fourth state of emergency in Tokyo from 12 July to 20 August, raising the possibility of no spectators attending the games. Meanwhile, Singapore is the only country that has decided to ease its social restrictions from 12 July, as new cases remain low. Urgency on vaccination The recent outbreaks in the region has alerted the authorities that the key to exiting the pandemic is to accelerate vaccine procurement and roll-out. -
En Este Número
Boletín Científico No. 18 (1-10 julio/2021) EN ESTE NÚMERO VacCiencia es una publicación dirigida a Resumen de candidatos vacu- investigadores y especialistas dedicados a nales contra la COVID-19 ba- la vacunología y temas afines, con el ob- sadas en la plataforma de sub- jetivo de serle útil. Usted puede realizar unidad proteica en desarrollo a sugerencias sobre los contenidos y de es- nivel mundial. (segunda parte) ta forma crear una retroalimentación Artículos científicos más que nos permita acercarnos más a sus recientes de Medline sobre necesidades de información. vacunas. Patentes más recientes en Patentscope sobre vacunas. Patentes más recientes en USPTO sobre vacunas. 1| Copyright © 2020. Todos los derechos reservados | INSTITUTO FINLAY DE VACUNAS Resumen de vacunas contra la COVID-19 basadas en la plataforma de subunidad proteica en desarrollo a nivel mundial (segunda parte) Las vacunas de subunidades antigénicas son aquellas en las que solamente se utilizan los fragmentos específicos (llamados «subunidades antigénicas») del virus o la bacteria que es indispensable que el sistema inmunitario reconozca. Las subunidades antigénicas suelen ser proteínas o hidratos de carbono. La mayoría de las vacunas que figuran en los calendarios de vacunación infantil son de este tipo y protegen a las personas de enfermedades como la tos ferina, el tétanos, la difteria y la meningitis meningocócica. Este tipo de vacunas solo incluye las partes del microorganismo que mejor estimulan al sistema inmunitario. En el caso de las desarrolladas contra la COVID-19 contienen generalmente, la proteína S o fragmentos de la misma como el Dominio de Unión al Receptor (RBD, por sus siglas en inglés). -
INTERNATIONAL STUDENT COVID VACCINE LIST and COMMUNICATION Dear International Student
INTERNATIONAL STUDENT COVID VACCINE LIST and COMMUNICATION Dear International Student We have provided a list of Selected Countries to help you find the COVID-19 vaccine you may have already received. Please see the “WHO” list below to find your COVID-19 vaccine, and if it has been APPROVED. And please upload your record following these directions: https://youtu.be/wvBGeRqIMHc If you see that your vaccine HAS NOT yet been approved by “WHO”, you may be required to receive an approved COVID-19 vaccine and upload those records to meet UC campus policy and requirements. Many US Airports are now providing COVID-19 vaccine on-site. Here is a list of several California Airports that you may arriving where you may receive a vaccine IMMEDIATELY upon your entry into the U.S. LAX – Los Angeles https://www.flylax.com/TravelSafely SNA – Orange County https://hoagurgentcare.com/airport/ SFO – San Francisco https://www.flysfo.com/travel-well/vaccination-site-sfo If you have any additional questions or concerns, please call (949)824-2300 for support. THANK YOU for helping to ensure UCI continues to be a SAFE and HEALTHY Campus! Dr Chang INDIA SOUTH KOREA TAIWAN INDONESIA VIETNAM JAPAN Vaccine Vaccine Vaccine Vaccine Vaccine Vaccine Oxford–AstraZeneca Oxford-AstraZeneca Sinovac Sputnik V Pfizer–BioNTech Covishield Pfizer–BioNTech Oxford–AstraZeneca Oxford–AstraZeneca Sinopharm Janssen Sinopharm Moderna Pfizer–BioNTech Moderna Pfizer–BioNTech Moderna Moderna Covaxin Novavax Moderna Johnson & Johnson Oxford–AstraZeneca Sputnik V Novavax Nanocovax Johnson & Johnson Sputnik V COVIVAC Sputnik V CanSino Vabiotech MVC-COV1901 ZyCoV-D Corbevax Covovax . -
31St May-6Th June Weekly Compilation
31st May -6th June Weekly Compilation (The Hindu+ Indian Express + PIB + Other World Wide News) PM CARES FOR CHILDREN SCHEME (Source: The HINDU) Why in News: The Prime Minister has announced a special PM-CARES for Children scheme. The scheme includes a comprehensive financial aid package for children orphaned during the pandemic. PM-CARES for Children Scheme The PM-CARES for Children Scheme will support children who have lost both parents or surviving parent or legal guardian/adoptive parents due to Covid-19. Features of the PM-CARES for Children Scheme Fixed Deposit in the name of the child . PM CARES will create a corpus of Rs 10 lakh for each child when s/he reaches 18 years of age. This corpus will be used to give monthly financial support from 18 years of age for the next five years. On reaching the age of 23 years, he or she will get the corpus amount as one lump sum for personal and professional use. School Education: For children under 10 years . The child will be given admission to the nearest Kendriya Vidyalaya or in a private school as a day scholar. If the child is admitted to a private school, the fees as per the Right to Education(RTE) norms will be given from the PM CARES. School Education: for children between 11-18 years: . The child will be given admission to any Central Government residential school such as Sainik School, Navodaya Vidyalaya etc. In case the child is to be continued under the care of Guardian. Then s/he will be given admission to the nearest Kendriya Vidyalaya or in a private school as a day scholar. -
CME INDIA COVID-19 Vaccination Protocol 2021 July Updat
COVID-19 VACCINATION PROTOCOL JULY 21 CME INDIA CME 1 CME INDIA CME INDIA COVID-19 Vaccination Protocol First published: 29th April 2021. Last Updated: 6th July 2021. With the rapid rise in Covid-19 cases in INDIA, CME INDIA has now compiled its own vaccination protocol with inputs from key medical experts. The goal of this document is to help the medical community in managing the current Covid-19 situation and provide insight into the COVID-19 Vaccination Program in India. This document will be updated from time to time, so please check www.cmeindia.in and CME INDIA Downloads section regularly. Alternatively, you can choose to navigate to the various key sections of CME INDIA: Explore CME INDIA Repository Examine CME INDIA Case Study Read History Today in Medicine Register for Future CMEs View CME INDIA Downloads 2 CME INDIA 3 CME INDIA Basic Framework By: Dr. Akash Singh, MD (Med) MSc (Diabetes) Consultant Physician and Diabetologist Spandan Multi Speciality Hospital, Vadodara. Dr. S. K. Gupta, MD (Med), FICP, CFM(France) Clinical Asst. Professor GS Medical College, CCSU, Uttar Pradesh India. Visiting Consultant, Max Super Specialty Hospital, New Delhi. Dr. Kiran Shah, Consultant Physician MBBS, MD, Spandan Multi Speciality Hospital Vadodara. Edited By: Dr. N.K. Singh, MD, FICP, Diabetologist Physician, Dhanbad, Editor - cmeindia.in. Advisor and Reviewer: Dr. Awadhesh Kumar Singh, Consultant Endocrinologist, G. D. Hospital & Diabetes Institute, Kolkata, West Bengal. Invitee Reviewer: Dr. Banshi Saboo, National President, RSSDI, Ahmedabad. Dr. Mangesh Tiwaskar, Consultant Physician & Diabetologist, Mumbai, Hon. General Secretary, API. Reviewer: Dr. R. Rajasekar, MD, FICP, FACP (USA), FRCP (Glasgow), FRCP (Ireland), Consultant Physician & Diabetologist Heart & Diabetes Therapy Centre, Kumbakonam, Tamil Nadu. -
0 February 2021 0
0 www.journalsofindia.com February 2021 1. 0 www.journalsofindia.com February 2021 0 www.journalsofindia.com February 2021 0 www.journalsofindia.com February 2021 0 www.journalsofindia.com February 2021 FOREIGN AFFAIRS ............................................................................................................................................................. 4 1. POST-BREXIT DEAL AND ITS CONSEQUENCES .................................................................................................................. 4 2. INDIA’S DRAFT ARCTIC POLICY ......................................................................................................................................... 4 3. STATUS OF RESIDENCE TO SPECIFIED SKILLED WORKERS IN JAPAN ................................................................................ 5 4. GREAT FIREWALL OF CHINA ............................................................................................................................................. 6 5. THE OFFICE OF THE HIGH COMMISSIONER FOR HUMAN RIGHTS(OHCHR)..................................................................... 6 6. THE INTERGOVERNMENTAL NEGOTIATIONS FRAMEWORK ON UNSC REFORMS ........................................................... 6 7. WORLD ECONOMIC FORUM ............................................................................................................................................ 7 8. WHITE SHIPPING INFORMATION: ................................................................................................................................... -
UPSC Daily Current Affairs | Prelim Bits 07-06-2021
UPSC Daily Current Affairs | Prelim Bits 07-06-2021 Kerala’s Smart Kitchen Project The Kerala government’s budget has set apart Rs 5 crore for the initial phase of the Smart Kitchen project. Purpose - This project is meant to modernise (mechanise) kitchens and ease the difficulty faced by homemakers in household chores. Under the scheme, KSFE would give soft loans to women from all walks of life for purchasing household gadgets or equipment. The cost of household equipment can be repaid as instalments within a particular period. The interest of the loan/cost would be equally shared among the beneficiary, local self-government body and the state government. The scheme would be implemented through the Kerala State Financial Enterprises (KSFE), a state-run chit fund and lending firm. To implement the scheme, KSFE would start smart kitchen chits. Preference - Members of Kudumbashree (Kerala’s women empowerment and poverty alleviation scheme) would get preference in purchasing kitchen gadgets under smart kitchen scheme. No collateral would be demanded from Kudumbashree members. Haryana’s Pran Vayu Devta Pension Scheme To avoid oxygen deficit in the future, the Haryana government has come out with a first of its kind initiative called “Pran Vayu Devta Pension Scheme (PVDPS)”. PVDPS - Haryana government will honour the trees which are of the age of 75 years and above and have served humanity throughout their life by producing oxygen, reducing pollution and so on. The Forest Department had commissioned a survey to identify these old trees throughout the state. Such trees will be looked after by involving local people in this scheme. -
Asia COVID-19 & Vaccine Tracker
18 June 2021 Free to View Asia COVID-19 & Vaccine Tracker Economics - Asia Waiting to re-open Herd immunity timelines are getting closer and closer in Noelan Arbis Economist Asia, thanks to increased vaccine supplies The Hongkong and Shanghai Banking Corporation Limited But pockets of concern still linger in the region, most recently Frederic Neumann in Indonesia and Vietnam Co-Head of Asian Economics Research The Hongkong and Shanghai Banking Corporation Limited As many Western economies begin to re-open, much of Asia Maitreyi Das continue to have restrictions in place, dragging down growth Associate Closer to herd immunity Vaccination rates in Asia continue to rise, bringing forward timelines for herd immunity. Based on our estimate, at least 10 economies in the region (from eight a week ago) are now slated to achieve herd immunity by end-2022 (Chart 6). Moreover, mainland China, South Korea, Singapore, Japan, and Hong Kong could achieve herd immunity by year-end, assuming the current pace of vaccinations continues. As herd immunity inches closer, economies with excess vaccine supply are contributing to others in Asia. Japan has committed to donate at least one million doses of the AstraZeneca vaccine each to Vietnam and Taiwan. It is also considering donating to Indonesia, Thailand, the Philippines, and Malaysia. Mainland China has also agreed to contribute 500,000 Sinovac doses to Malaysia. Vaccine efficacy concerns While things are broadly improving across Asia, there are still some pockets of concern. Indonesia's new cases are on the rise again weeks after the Eid Al-Fitr holidays (Chart 7). Vietnam's cases are also on the rise, most of which are in the business centre of Ho Chi Minh City (Chart 12). -
Corbevax Covid-19 Vaccine
Corbevax Covid-19 Vaccine drishtiias.com/printpdf/corbevax-covid-19-vaccine Why in News India has placed an advance order to block 300 million doses of a new Covid-19 vaccine, Corbevax. Key Points Corbevax: About: It is India’s indigenous Covid-19 vaccine which is currently undergoing Phase 3 clinical trials. Working: It is a “recombinant protein sub-unit” vaccine. It means it is made up of a specific part of SARS-CoV-2 - the spike protein on the virus’s surface. The spike protein allows the virus to enter the cells in the body so that it can replicate and cause disease. However, when this protein alone is given to the body, it is not expected to be harmful as the rest of the virus is absent. The body is expected to develop an immune response against the injected spike protein. Therefore, when the real virus attempts to infect the body, it will already have an immune response ready that will make it unlikely for the person to fall severely ill. 1/2 Difference between Corbevax and Other Covid-19 Vaccines: They are either mRNA vaccines (Pfizer and Moderna), viral vector vaccines (Covishield and Sputnik V) or inactivated vaccines (Covaxin, Sinovac- CoronaVac and Sinopharm’s Vero Cell). Viral vector and mRNA vaccines use a code to induce our cells to make the spike proteins against which the body has to build immunity. In the case of Corbevax, protein itself is given. mRNA vaccines work by using messenger RNA (mRNA), which is the molecule that essentially puts DNA instructions into action. -
Civil Services Monthly June 2021
CIVIL SERVICES MONTHLY JUNE 2021 “AMBITAG“ Delta variant of covid-19 Dihing Patkai is Assam’s 7th National Park UNDP Report Lauds Aspirational Districts Programme ‘Jivan Vayu’ ‘ITAT E-DWAR‘ Nuclear-capable Agni-P missile test-fired ONE STOP SOLUTION FOR CIVILONE STOP FOR SERVICES SOLUTION NATRAX- the High Speed Track(HST) in Indore A Greener Urbanscape Opening the UAPA Box DO NOT HARM: conversion therapy Delhi’s sea blindness Bad Bank lessons from China restoration of degraded land in India INDEX PRELIMS "AmbiTAG" 01 Centre's fiscal deficit for FY21 settles at 9.2% of GDP 01 India's GDP contracted by 7.3% in 2021 as per NSO 02 Recent MOU on Digital ecosystem of Agriculture 02 Initiatives around Compressed Bio Gas to give filip to SATAT scheme 03 ‘India Cycles4Change’ 04 “Cooperation in the field of Mass Media” among SCO members 05 Union cabinet approved the Model Tenancy Act 06 Wheat procured with all time high MSP value 06 Delta variant of covid-19 07 Indian Railways on way to become “Largest Green Railways” in the world 08 India’s First Indigenous Tumour Antigen SPAG9 09 INS Sandhayak decommissioned 09 Punjab, T.N. and Kerala top education index ranking 10 Niclosamide for treatment of Covid-19 10 Van Dhan Yojana in the Union Territory of Ladakh 11 Maldives wins UNGA election 11 World Bank sees India growing by 8.3% 11 Rengma Nagas demand autonomous council 12 first commercial consignment of GI certified Jardalu mangoes is exported 12 First CAR-T cell therapy conducted 13 India-Thailand Coordinated Patrol (Indo-Thai CORPAT) 13 Centre announces hike in MSP for paddy, pulses, oilseeds 14 Dihing Patkai is Assam’s 7th National Park 14 Biden, Johnson seek to sign ‘new Atlantic Charter’ 14 CHIME telescope yields unprecedented results 14 Maharashtra govt. -
COVID-19 in India: Disease Burden, Managing the Second Wave and Innovations
CSD Working Paper Series: Towards a New Indian Model of Information and Communications Technology-Led Growth and Development COVID-19 in India: Disease Burden, Managing the second wave and Innovations ICT India Working Paper #54 Nirupam Bajpai and Manisha Wadhwa August 2021 CSD Working Paper Series - COVID-19 in India: Disease Burden, Managing the second wave and Innovations Table of Contents Executive Summary ....................................................................................................................................... 5 Introduction .................................................................................................................................................. 6 COVID-19 Vaccination Drive ....................................................................................................................... 10 Challenges related to COVID-19 vaccination Drive ................................................................................. 13 Gaps in Digital Platform ...................................................................................................................... 13 Shortage of Vaccine ............................................................................................................................ 13 Vaccine Wastage ................................................................................................................................. 13 Rural Challenge .................................................................................................................................. -
Current Affairs (Consolidation)
Current Affairs (CONSOLIDATION) JUNE 2021 (PART – I) Drishti, 641, First Floor, Dr. Mukherjee Nagar, Delhi-110009 Phone: 87501 87501, WhatsApp: 92058 85200, IVR: 8010-440-440 Email: [email protected] Contents Polity and Governance ........................................................................................................1 zz Revised Subsidy for Electric Vehicles ...................................................................................................................... 1 zz National AI Portal ................................................................................................................................................... 2 zz Beed Model of Pradhan Mantri Fasal Bima Yojana ................................................................................................ 3 zz QS WorldUniversity Rankings 2022 ........................................................................................................................ 5 zz Swachh BharatMission Grameen Phase-II .............................................................................................................. 6 zz I-Familia: Global Databaseto Identify Missing Persons .......................................................................................... 7 zz New PensionRules for Civil Servants ...................................................................................................................... 8 zz Section 51 of the Disaster Management Act, 2005 ...............................................................................................